ScreenYu Gyn® is an in-vitro molecular diagnostic test for gynecological cancer detection and risk assessment. This PCR-based assay identifies clinically relevant biomarkers to support cervical and gynecological pathology diagnosis and patient stratification.
Manufactured by
Epitype GmbH
Jena, Germany
Epitype was initially founded as oncgnostics GmbH in early 2012 as a spin-off from the Department of Gynecology at Jena University Hospital. The foundation for the company’s establishment was laid within the framework of an EU collaborative project (INCA – Infections and Cancer) during research on epigenetic markers in the development of cervical cancer in the Department of Gynecological Molecular Biology (Prof. Dürst). A successful EXIST research transfer project enabled the preparation for founding the company. From the goal of improving early cervical cancer detection, the product GynTect®, a molecular biological test for cervical cancer, emerged and has been on the market since 2015. The developed cancer tests are used in early cancer detection and diagnosis. Since 2025, Epitype GmbH has been further advancing the widespread application of its innovations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
Access Bio, Inc.
United States · 2 relevant products
Attogen Biomedical(Suzhou)Ltd.Inc
China · 1 relevant product
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 106 closest product alternatives
HLB PANAGENE Co., Ltd. · South Korea
A molecular screening test for human papillomavirus detection in clinical samples supporting cervical cancer prevention programs.
Access Bio, Inc. · United States
Molecular test for human papillomavirus detection and screening. PCR-based detection for cervical cancer risk assessment.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products